Evidence map›Paper›PMID 41212294›Full record

ArticleMolecular neurobiology2025

Neuroprotective Effects of Rhamnosyl Icariside II in 6-OHDA-Treated PC12 Cells and Zebrafish.

Fen Zhang, Gege Liu, Wang Chen, Baobing Zhao

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fen ZhangSchool of Biological Science and Engineering, Shaanxi University of Technology, Hanzhong, 723000, China.
Gege LiuSchool of Biological Science and Engineering, Shaanxi University of Technology, Hanzhong, 723000, China.
Wang ChenSchool of Biological Science and Engineering, Shaanxi University of Technology, Hanzhong, 723000, China. chenwang@snut.edu.cn.
Baobing ZhaoSchool of Pharmaceutical Sciences, Shandong University, Jinan, Shandong, 250012, People's Republic of China.

Funding

Key Technology Research and Development Foundation of Science and Technology De-partment of Shaanxi Province 2024QY2-GJHX-17Project of Qinba State Key Laboratory of Biological Resources and Ecological Environment (Incubation) SXC-2302Special Scientific Research Projects for Local Service of Education Department of Shaanxi Province 24JC026
6 · The paper itself

Abstract

This study evaluated the neuroprotective efficacy and molecular mechanisms of Rhamnosyl Icariside II (RIC), a rare secondary flavonoid glycoside from Epimedium Linn plants, in 6-hydroxydopamine-induced PC12 cell and zebrafish PD models. RIC demonstrated effective prophylactic protection and reparative effects, significantly improving PC12 cell viability in both the pretreatment and postinjury models. RIC alleviated oxidative stress by reducing lactate dehydrogenase (LDH) activity and reactive oxygen species (ROS) levels, while simultaneously increasing the activities of superoxide dismutase (SOD) and glutathione (GSH). RT-qPCR and Western blot analyses revealed that RIC inhibited the intrinsic mitochondrial apoptotic pathway by upregulating the antiapoptotic protein Bcl-2, suppressing the activation of pro-apoptotic Bax, cleaved caspase-3 and caspase-9, and inhibiting the release of cytochrome c from mitochondria. RIC effectively restored motor coordination impaired by 6-OHDA in the zebrafish PD model. Collectively, RIC exhibits significant neuroprotective potential through synergistic regulation of oxidative stress and modulation of the intrinsic mitochondrial apoptotic pathway. Therefore, this study suggests that RIC could be a promising option for the treatment or prevention of neurodegenerative disorders, particularly PD.

Indexed as

FlavonoidsNeuroprotective AgentsOxidopamineAnimalsApoptosisCell SurvivalMitochondriaOxidative StressPC12 CellsRatsReactive Oxygen SpeciesZebrafishbaohuoside IFlavonoidsNeuroprotective AgentsOxidopamineReactive Oxygen Species6-HydroxydopamineNeuroprotective effectsPC12 cellsRhamnosyl Icariside IIZebrafish

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.